tiprankstipranks
Trending News
More News >
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
US Market

Karyopharm Therapeutics (KPTI) Cash flow

Compare
1,206 Followers

Karyopharm Therapeutics Cash Flow

KPTI's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, KPTI's free cash flow was decreased by $-34.91M and operating cash flow was $0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -127.49M$ -92.72M$ -149.55M$ -107.12M$ -160.23M
Investing Cash Flow
$ 95.47M$ 7.94M$ -104.26M$ 141.84M$ -53.69M
Financing Cash Flow
$ 41.65M$ 1.12M$ 193.74M$ 73.65M$ 172.08M
End Cash Position
$ 62.81M$ 53.19M$ 136.88M$ 197.44M$ 89.12M
Free Cash Flow
$ -127.63M$ -92.72M$ -149.67M$ -112.83M$ -160.38M
Currency in USD

Karyopharm Therapeutics Cash Flow